These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14642437)

  • 1. Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum.
    Süssmuth SD; Tumani H; Ecker D; Ludolph AC
    Neurosci Lett; 2003 Dec; 353(1):57-60. PubMed ID: 14642437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
    Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
    Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of S100 beta protein in serum of patients with amyotrophic lateral sclerosis.
    Otto M; Bahn E; Wiltfang J; Boekhoff I; Beuche W
    Neurosci Lett; 1998 Jan; 240(3):171-3. PubMed ID: 9502231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
    Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
    Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau, phospho-tau, and S-100B in the cerebrospinal fluid of children with multiple sclerosis.
    Rostasy K; Withut E; Pohl D; Lange P; Ciesielcyk B; Diem R; Gärtner J; Otto M
    J Child Neurol; 2005 Oct; 20(10):822-5. PubMed ID: 16417878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis.
    Lehnert S; Costa J; de Carvalho M; Kirby J; Kuzma-Kozakiewicz M; Morelli C; Robberecht W; Shaw P; Silani V; Steinacker P; Tumani H; Van Damme P; Ludolph A; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):344-50. PubMed ID: 24575871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine kinase activity in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z
    Neurol Sci; 2003 Nov; 24(4):286-7. PubMed ID: 14658051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis.
    Ito D; Hashizume A; Hijikata Y; Yamada S; Iguchi Y; Iida M; Kishimoto Y; Moriyoshi H; Hirakawa A; Katsuno M
    J Neurol; 2019 Dec; 266(12):2952-2961. PubMed ID: 31456060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.
    Jesse S; Steinacker P; Cepek L; von Arnim CA; Tumani H; Lehnert S; Kretzschmar HA; Baier M; Otto M
    J Alzheimers Dis; 2009; 17(3):541-51. PubMed ID: 19433893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of CSF NfL and tau in ALS.
    Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
    J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Nagata T; Nagano I; Shiote M; Narai H; Murakami T; Hayashi T; Shoji M; Abe K
    Neurol Res; 2007 Dec; 29(8):772-6. PubMed ID: 17672928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.
    Sjögren M; Davidsson P; Wallin A; Granérus AK; Grundström E; Askmark H; Vanmechelen E; Blennow K
    Dement Geriatr Cogn Disord; 2002; 13(2):112-8. PubMed ID: 11844893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.
    Green AJ; Thompson EJ; Stewart GE; Zeidler M; McKenzie JM; MacLeod MA; Ironside JW; Will RG; Knight RS
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):744-8. PubMed ID: 11385008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.
    Sanchez-Juan P; Sánchez-Valle R; Green A; Ladogana A; Cuadrado-Corrales N; Mitrová E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Krasnianski A; Equestre M; Slivarichová D; Saiz A; Calero M; Pocchiari M; Knight R; van Duijn CM; Zerr I
    J Neurol; 2007 Jul; 254(7):901-6. PubMed ID: 17385081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum level of CNTF is elevated in patients with amyotrophic lateral sclerosis and correlates with site of disease onset.
    Laaksovirta H; Soinila S; Hukkanen V; Röyttä M; Soilu-Hänninen M
    Eur J Neurol; 2008 Apr; 15(4):355-9. PubMed ID: 18353124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of S100B and Tau protein concentrations in the cerebrospinal fluid for the differential diagnosis of bacterial meningitis: a retrospective analysis.
    Jung K; Goerdt C; Lange P; Blocher J; Djukic M; Gerber J; Spreer A; Nau R; Otto M; Schmidt H
    Eur Neurol; 2011; 66(3):128-32. PubMed ID: 21865761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.